US Stock Market Move | Moderna (MRNA.US) rose over 9% after news of negotiations for acquisition with at least one major pharmaceutical company.
As of the time of writing, the stock has risen by more than 9%, reaching $26.95 per share.
On Thursday, Moderna's stock price (MRNA.US) rose, up more than 9% to $26.95 as of press time. In terms of news, a person familiar with the matter revealed that the company is in acquisition negotiations with at least one major pharmaceutical company for a large-scale deal.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
